Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-237-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20110216.11.3-237-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
".
There has been an alarming increase in counterfeit medicines in the EU. They may contain inferior quality, counterfeit or inaccurately measured substances, whether active or not, or they may contain no active substances at all, and thus pose a serious danger to the patient. For industry, the direct and indirect social costs of taking no action on this certainly amount to more than EUR 10 billion. Together with the Group of the Greens/European Free Alliance in the European Parliament, I support this agreement. It brings existing rules up to date and introduces safety features which ensure the identification, authentication and traceability of the product, whilst regulating the sale of medicines on the Internet. That is
of the main routes by which counterfeit drugs end up on the European market. It is estimated that more than 50% of medicines purchased over the Internet on sites which do not specify their actual physical address are counterfeit.
We therefore have to distinguish between legitimate mail order or Internet pharmacies and the illegal distribution chain, which includes uncontrolled Internet purchases. A legitimate mail order pharmacy must be connected to a legally registered pharmacy and we have to make sure that any legitimate mail order pharmacy complies with all the legal requirements which apply to pharmacies in the Member State where it is legally established."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples